1. Home
  2. ZYXI vs INGN Comparison

ZYXI vs INGN Comparison

Compare ZYXI & INGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZYXI
  • INGN
  • Stock Information
  • Founded
  • ZYXI 1996
  • INGN 2001
  • Country
  • ZYXI United States
  • INGN United States
  • Employees
  • ZYXI N/A
  • INGN N/A
  • Industry
  • ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • INGN Industrial Specialties
  • Sector
  • ZYXI Health Care
  • INGN Health Care
  • Exchange
  • ZYXI Nasdaq
  • INGN Nasdaq
  • Market Cap
  • ZYXI 72.3M
  • INGN N/A
  • IPO Year
  • ZYXI N/A
  • INGN 2014
  • Fundamental
  • Price
  • ZYXI $2.40
  • INGN $7.49
  • Analyst Decision
  • ZYXI Buy
  • INGN Strong Buy
  • Analyst Count
  • ZYXI 3
  • INGN 3
  • Target Price
  • ZYXI $6.00
  • INGN $11.00
  • AVG Volume (30 Days)
  • ZYXI 252.8K
  • INGN 205.7K
  • Earning Date
  • ZYXI 07-24-2025
  • INGN 08-05-2025
  • Dividend Yield
  • ZYXI N/A
  • INGN N/A
  • EPS Growth
  • ZYXI N/A
  • INGN N/A
  • EPS
  • ZYXI N/A
  • INGN N/A
  • Revenue
  • ZYXI $172,401,000.00
  • INGN $339,960,000.00
  • Revenue This Year
  • ZYXI N/A
  • INGN $7.46
  • Revenue Next Year
  • ZYXI $19.55
  • INGN $6.03
  • P/E Ratio
  • ZYXI N/A
  • INGN N/A
  • Revenue Growth
  • ZYXI N/A
  • INGN 5.73
  • 52 Week Low
  • ZYXI $1.66
  • INGN $5.70
  • 52 Week High
  • ZYXI $10.62
  • INGN $13.33
  • Technical
  • Relative Strength Index (RSI)
  • ZYXI 49.51
  • INGN 68.13
  • Support Level
  • ZYXI $2.51
  • INGN $6.86
  • Resistance Level
  • ZYXI $2.72
  • INGN $7.30
  • Average True Range (ATR)
  • ZYXI 0.20
  • INGN 0.33
  • MACD
  • ZYXI 0.02
  • INGN 0.09
  • Stochastic Oscillator
  • ZYXI 48.78
  • INGN 92.54

About ZYXI Zynex Inc.

Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.

Share on Social Networks: